Is a complete NSE/AARTIDRUGS research report available?

No complete published report is available for nse/AARTIDRUGS (NSE/AARTIDRUGS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/AARTIDRUGS stock profile: metrics, valuation and analysis

Market cap	38.7B
Revenue (ttm)	26.8B
Net income (ttm)	1.9B
EPS (ttm)	₹20.9
P/E (trailing)	20.2x
P/E (forward)	17.1x
Dividend	₹2.00 (0.47%)
Volume	108,126
Beta	0.35

All NSE/AARTIDRUGS indicators

Market & fundamental data

Available fields

223

Groups with data

Currency

INR

Showing 223 of 223 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,284
Employees Change	220%
Employees Change Percent	20.68
Enterprise value	INR 44.2B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	39.88
Industry PE Fwd	34.19
Isin	INE767A01016
Last refreshed	2026-09-10
Market cap	INR 38.7B
Price	INR 423
Price currency	INR
Rev Per Employee	19,760,738.01x
Sector	Healthcare
Sector PE	48.25
Sector PE Fwd	38.68
Sic	2836
Symbol	nse/AARTIDRUGS
Website	https://www.aartidrugs.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.94%
EV Earnings	23.14x
EV/EBIT	16.66x
EV/EBITDA	13.17x
EV/FCF	55.15x
EV/Sales	1.65x
FCF yield	2.07%
Forward P/E	17.12x
P/B ratio	2.5x
P/E ratio	20.25x
P/S ratio	1.45x
PE Ratio10 Y	20.15x
PE Ratio3 Y	23.25x
PE Ratio5 Y	23.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	9.92%
EBITDA Margin	12.55%
FCF margin	3.13%
Gross margin	37.52%
Gross Profit	INR 10B
Gross Profit Growth	16.15%
Gross Profit Growth Q	27.11%
Gross Profit Growth3 Y	5.78%
Gross Profit Growth5 Y	4.87%
Net Income	INR 1.9B
Net Income Growth	1.25%
Net Income Growth Q	-6.94%
Net Income Growth Qo Q	-9.1%
Net Income Growth Years	1%
Net Income Growth3 Y	2.15%
Net Income Growth5 Y	-4.74%
Pretax Margin	8.55%
Profit Margin	7.14%
Profit Per Employee	INR 1.4M
Profitable Quarters	INR 57
Profitable Years	21
Roa5y	6.85
Roe5y	15.17
ROIC	10.54
Roic5y	11.73

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	13.64%
Cagr15y	26.7%
Cagr1y	-10.79%
Cagr20y	22.55%
Cagr3y	-11.63%
Cagr5y	-6.77%
Div CAGR10	1.71%
Div CAGR3	25.99%
Div CAGR5	-7.79%
EPS Growth	1.45
EPS Growth Q	-7.05
EPS Growth Qo Q	-9.26
EPS Growth Years	1
EPS Growth3 Y	2.63
EPS Growth5 Y	-4.37
FCF Growth	18.98%
FCF Growth5 Y	3.75%
OCF Growth	3.66%
OCF Growth10 Y	6.64%
OCF Growth3 Y	23.89%
OCF Growth5 Y	10.35%
Revenue Growth	10.56x
Revenue Growth Q	19.15x
Revenue Growth Qo Q	-2.32x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.94x
Revenue Growth5 Y	4.11x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 242.8M
Debt	INR 5.8B
Debt EBITDA	INR 1.72
Debt Equity	INR 0.37
Debt FCF	INR 7.19
Equity	INR 15.5B
Interest Coverage	7.72
Net Cash	INR -5.5B
Net Cash By Market Cap	INR -14.27
Net Debt EBITDA	INR 1.64
Net Debt Equity	INR 0.36
Net Debt FCF	INR 6.89
Tangible Book Value	INR 15.3B
Tangible Book Value Per Share	INR 168
WACC	6.04

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.19%
Dividend Growth	100%
Dividend Growth Years	0%
Dividend per share	INR 2
Dividend Years	5
Dividend Yield	0.47%
Ex Div Date	2026-02-09
Last Dividend	INR 2
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	258.95%
1Y total return	-10.79%
200-day SMA	387.5
3Y total return	-30.99%
50-day SMA	413.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-29.57%
All Time High	1,027
All Time High Change	-58.77%
All Time High Date	2020-10-08
All Time Low	3.95
All Time Low Change	10,620.25%
All Time Low Date	2009-02-20
ATR	13.24
Beta	0.35
Ch YTD	2.87
High	431
High52	534.6
High52 Date	2025-09-19
High52ch	-20.78%
Low	421.5
Low52	319
Low52 Date	2026-03-30
Low52ch	32.76%
Ma50ch	2.46%
Price vs 200-day SMA	9.28%
RSI	53.48
RSI Monthly	49.98
RSI Weekly	57.35
Sharpe ratio	-0.42x
Sharpe Ratio3y	-0.21x
Sharpe Ratio5y	-0.16x
Sortino ratio	-0.42
Sortino Ratio3y	-0.15
Sortino Ratio5y	-0.09
Total Return	0.66%
Tr YTD	3.42
Tr15y	3,380.58%
Tr1m	1.74%
Tr1w	-0.85%
Tr3m	15.68%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	35,372,091%
Net Borrowing	-269,800,000
Shares Insiders	47.31%
Shares Institutions	18.01%
Shares Qo Q	0.18%
Shares Yo Y	-0.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	145,611.5x
Bv Per Share	169.8
CAPEX	INR -1.7B
Ch10y	249.5
Ch15y	2,787.9
Ch1m	1.74
Ch1w	-0.85
Ch1y	-11.26
Ch20y	3,956.8
Ch3m	15.68
Ch3y	-31.65
Ch5y	-30.55
Ch6m	18.58
Change	0.46%
Change From Open	0.46
Close	421.5
Days Gap	0
Depreciation Amortization	704,516,000
Dollar Volume	45,785,954.7
Earnings Date	2026-10-21
EBIT	INR 2.7B
EBITDA	INR 3.4B
EPS	INR 20.95
F Score	4
FCF	INR 802.2M
FCF EV Yield	1.81x
Financing CF	-774,400,000
Fiscal Year End	March
Founded	1,984
Graham Number	282.37373
Graham Upside	-33.32
Income Tax	INR 379.4M
Investing CF	-1,734,100,000
Is Primary Listing	0
Last Earnings Date	2026-07-31
Last Report Date	2026-06-30
Last Split Date	2020-09-30
Last Split Type	Forward
Lynch Fair Value	INR 105
Lynch Upside	-75.31
Ma150	383.3
Ma150ch	10.48%
Ma20	419.4
Ma20ch	0.97%
Net CF	26,900,000
Next Earnings Date	2026-10-21
Open	421.5
P FCF Ratio	48.26
P OCF Ratio	15.27
Payment Date	2026-03-05
Position In Range	20.63
Price Date	2026-09-09
Price EBITDA	INR 11.52
Ptbv Ratio	2.53
Relative Volume	0.74x
Revenue	26,775,800,000x
Tax By Revenue	1.42x
Tax Rate	16.56%
Tr20y	5,733.22%
Tr6m	18.58%
Volume	108,126

NSE/AARTIDRUGS (NSE/AARTIDRUGS)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/AARTIDRUGS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/AARTIDRUGS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/AARTIDRUGS

Frequently asked questions